Development of a Limosilactobacillus reuteri therapeutic delivery platform with reduced colonization potential.
Alexander LM, Khalid S, Gallego-Lopez GM, Astmann TJ, Oh J-H, Heggen M, Huss P, Fisher R, Mukherjee A, Raman S, Choi IY, Smith MN, Rogers CJ, Epperly MW, Knoll LJ, Greenberger JS, van Pijkeren J-P.
Alexander LM, et al.
Appl Environ Microbiol. 2024 Nov 20;90(11):e0031224. doi: 10.1128/aem.00312-24. Epub 2024 Oct 31.
Appl Environ Microbiol. 2024.
PMID: 39480094
Free PMC article.